Function and regulation of the complement system in cardiovascular diseases
Riina Oksjoki1, Petri T Kovanen, Seppo Meri
1Wihuri Research Institute, Helsinki, Finland.
Insights
The complement system is crucial in immunity and cardiovascular diseases like atherosclerosis. Limiting its excessive activation may offer therapeutic benefits for heart conditions.
Area of Science:
- Immunology
- Cardiovascular Biology
- Pathophysiology
Background:
- The complement system is a key component of innate and adaptive immunity.
- Complement activation is implicated in various cardiovascular diseases, including atherosclerosis, aneurysms, and ischemic heart disease.
- Dysregulation of complement, particularly defects in the classical pathway, can lead to conditions like vasculitis and atherosclerosis.
Purpose of the Study:
- To describe complement activation and regulation in cardiovascular diseases.
- To discuss the therapeutic potential of modulating complement activity in cardiovascular disorders.
Main Methods:
- Review of existing literature on complement system's role in cardiovascular diseases.
- Analysis of evidence from experimental animal models.
Main Results:
- Complement is significantly activated in atherosclerotic lesions, arterial aneurysms, and cardiac tissue affected by ischemia or failure.
- Evidence suggests that limiting excessive complement activation could be therapeutically beneficial.
- Deficiencies in the classical complement pathway are linked to increased risk of vasculitis and atherosclerosis, potentially due to impaired clearance of apoptotic cells and immune complex handling.
Conclusions:
- Complement system plays a dual role in cardiovascular diseases, contributing to pathology when overactivated but also being essential for normal function.
- Modulating complement activation presents a promising therapeutic strategy for cardiovascular diseases.
- Further research, particularly in animal models, supports the potential of complement-targeted therapies.
Abstract:
The complement system plays a central role in innate immunity and also regulates adaptive immunity. The complement system has been demonstrated to contribute to various diseases, including cardiovascular diseases. Complement is extensively activated in atherosclerotic lesions, in arterial aneurysms, and in the myocardium of ischemic and failing hearts. Accumulating evidence shows that limitation of excessive complement activation under these conditions may hold therapeutic value. On the other hand, defects in the classical complement pathway predispose to vasculitis and atherosclerosis, possibly due to ineffective clearance of apoptotic/necrotic cells and abnormal processing of immune complexes. Here, we describe complement activation and regulation in cardiovascular diseases and discuss the evidence derived mainly from experimental animals suggesting that modulation of complement activation may alter the course of these disorders.
Related Concept Videos
Complement System
Regulation of the Cardiovascular System
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Acute Inflammation III: Local and Systemic Effects
Antimicrobial Proteins
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...


